Product Name

  • Name

    Niflumic acid

  • EINECS 224-516-2
  • CAS No. 4394-00-7
  • Article Data14
  • CAS DataBase
  • Density 1.449 g/cm3
  • Solubility 19mg/L(room temperature)
  • Melting Point 203-204 °C
  • Formula C13H9F3N2O2
  • Boiling Point 378 °C at 760 mmHg
  • Molecular Weight 282.222
  • Flash Point 182.4 °C
  • Transport Information UN 2811 6.1/PG 3
  • Appearance Pale yellow crystalline powder
  • Safety 26-36/37/39
  • Risk Codes 20/21/22-36/37/38
  • Molecular Structure Molecular Structure of 4394-00-7 (Niflumic acid)
  • Hazard Symbols HarmfulXn
  • Synonyms 2-[[3-(trifluoromethyl)phenyl]amino]pyridine-3-carboxylate;Aza-2 dimethyl-2,3 (tetrazolyl-5)-6 diphenylamino;Nicotinic acid, 2-(alpha,alpha,alpha-trifluoro-m-toluidino)-;Acidum niflumicum;Acide niflumique;Acido niflumico;2-[(3-trifluoromethyl) phenyl] amino-3-pyridine-carboxylic acid;Forenol;Actol;2-(3-(Trifluoromethyl)anilino)nicotinic acid;Landruma;Nifumic acid USP24;2-{[3-(Trifluoromethyl)phenyl]amino}nicotinic acid;carboxamido)-2-heptenoic acid Niflumic acid;3-Pyridinecarboxylic acid, 2-((3-(trifluoromethyl)phenyl)amino)-;
  • PSA 62.22000
  • LogP 3.61520

Synthetic route

2-chloronicotinic acid
2942-59-8

2-chloronicotinic acid

3-trifluoromethylaniline
98-16-8

3-trifluoromethylaniline

Niflumic Acid
4394-00-7

Niflumic Acid

Conditions
ConditionsYield
With pyridine; toluene-4-sulfonic acid In water Heating;
With potassium iodide at 100 - 140℃; for 1.5h;
1-(3'-trifluoromethylphenyl)-2-methyl-4H-1,2-dihydro-pyrido-<2,3-d>-<1,3>-oxazin-4-one
137488-50-7

1-(3'-trifluoromethylphenyl)-2-methyl-4H-1,2-dihydro-pyrido-<2,3-d>-<1,3>-oxazin-4-one

Niflumic Acid
4394-00-7

Niflumic Acid

Conditions
ConditionsYield
With water In methanol at 20℃; Rate constant; pH from 4.0 to 9.0, half-live-time;
1-(3'-trifluoromethylphenyl)-4H-1,2-dihydro-pyrido-<2,3-d>-<1,3>-oxazin-4-one
137488-34-7

1-(3'-trifluoromethylphenyl)-4H-1,2-dihydro-pyrido-<2,3-d>-<1,3>-oxazin-4-one

Niflumic Acid
4394-00-7

Niflumic Acid

Conditions
ConditionsYield
With water In methanol at 20℃; Rate constant; pH from 4.0 to 9.0, half-live-time;
1-(3'-trifluoromethylphenyl)-2-methoxy-4H-1,2-dihydro-pyrido-<2,3-d>-<1,3>-oxazin-4-one
137488-47-2

1-(3'-trifluoromethylphenyl)-2-methoxy-4H-1,2-dihydro-pyrido-<2,3-d>-<1,3>-oxazin-4-one

Niflumic Acid
4394-00-7

Niflumic Acid

Conditions
ConditionsYield
With water In methanol at 20℃; Rate constant; pH from 4.0 to 8.0, half-live-time;
1-(3'-trifluoromethylphenyl)-2-chloromethyl-4H-1,2-dihydro-pyrido-<2,3-d>-<1,3>-oxazin-4-one
137488-49-4

1-(3'-trifluoromethylphenyl)-2-chloromethyl-4H-1,2-dihydro-pyrido-<2,3-d>-<1,3>-oxazin-4-one

Niflumic Acid
4394-00-7

Niflumic Acid

Conditions
ConditionsYield
With water In methanol at 20℃; Rate constant; pH from 4.0 to 9.0, half-live-time;
1-(3'-trifluoromethylphenyl)-2-ethoxy-4H-1,2-dihydro-pyrido-<2,3-d>-<1,3>-oxazin-4-one
137488-48-3

1-(3'-trifluoromethylphenyl)-2-ethoxy-4H-1,2-dihydro-pyrido-<2,3-d>-<1,3>-oxazin-4-one

Niflumic Acid
4394-00-7

Niflumic Acid

Conditions
ConditionsYield
With water In methanol at 20℃; Rate constant; pH from 4.0 to 8.0, half-live-time;
2-<<3-(Trifluormethyl)phenyl>amino>3-pyridincarbonsaeure-2-oxopropylester
137138-26-2

2-<<3-(Trifluormethyl)phenyl>amino>3-pyridincarbonsaeure-2-oxopropylester

Niflumic Acid
4394-00-7

Niflumic Acid

Conditions
ConditionsYield
With buffer pH 8.0 In 1,4-dioxane; acetonitrile at 57℃; half-life time of hydrolysis at different pH;
3-morpholinopropyl 2-(3-(trifluoromethyl)phenylamino)pyridine-3-carboxylate
929257-58-9

3-morpholinopropyl 2-(3-(trifluoromethyl)phenylamino)pyridine-3-carboxylate

A

4-(1-hydroxypropyl)morpholine
5835-79-0

4-(1-hydroxypropyl)morpholine

B

Niflumic Acid
4394-00-7

Niflumic Acid

Conditions
ConditionsYield
In phosphate buffer at 37℃; for 48h; pH=7.4; Kinetics; Further Variations:; Solvents; reaction times;
4-morpholinobutyl 2-(3-(trifluoromethyl)phenylamino)pyridine-3-carboxylate
929257-57-8

4-morpholinobutyl 2-(3-(trifluoromethyl)phenylamino)pyridine-3-carboxylate

A

5-(morpholin-4-yl)pentan-1-ol
4344-62-1

5-(morpholin-4-yl)pentan-1-ol

B

Niflumic Acid
4394-00-7

Niflumic Acid

Conditions
ConditionsYield
In phosphate buffer at 37℃; for 48h; pH=7.4; Kinetics; Further Variations:; Solvents; reaction times;
2-(3-trifluoromethyl-phenylamino)nicotinic acid propylcarbamoylmethyl ester
735318-84-0

2-(3-trifluoromethyl-phenylamino)nicotinic acid propylcarbamoylmethyl ester

A

propylamine
107-10-8

propylamine

B

Niflumic Acid
4394-00-7

Niflumic Acid

C

glycolic acid proylamide
104749-83-9

glycolic acid proylamide

Conditions
ConditionsYield
With potassium chloride In phosphate buffer; acetonitrile at 37℃; for 0.266667h; pH=7.4; Kinetics; Enzymatic reaction;
N,N-diethylcarbamoylmethyl 2-[3-(trifluoromethyl)anilino]nicotinic ester
533925-39-2

N,N-diethylcarbamoylmethyl 2-[3-(trifluoromethyl)anilino]nicotinic ester

A

N,N-diethyl-2-hydroxyacetamide
39096-01-0

N,N-diethyl-2-hydroxyacetamide

B

Niflumic Acid
4394-00-7

Niflumic Acid

C

diethylamine
109-89-7

diethylamine

Conditions
ConditionsYield
With potassium chloride In phosphate buffer; acetonitrile at 37℃; for 0.266667h; pH=7.4; Kinetics; Enzymatic reaction;
morpholinocarbamoylmethyl 2-[3-(trifluoromethyl)anilino]nicotinic ester
533925-45-0

morpholinocarbamoylmethyl 2-[3-(trifluoromethyl)anilino]nicotinic ester

A

morpholine
110-91-8

morpholine

B

2-hydroxy-1-(morpholin-4-yl)ethan-1-one
51068-78-1

2-hydroxy-1-(morpholin-4-yl)ethan-1-one

C

Niflumic Acid
4394-00-7

Niflumic Acid

Conditions
ConditionsYield
With potassium chloride In phosphate buffer; acetonitrile at 37℃; for 0.266667h; pH=7.4; Kinetics; Enzymatic reaction;
Niflumic Acid
4394-00-7

Niflumic Acid

o-toluidine
95-53-4

o-toluidine

N-o-tolyl-2-(3-trifluoromethyl-anilino)-nicotinamide
31991-24-9

N-o-tolyl-2-(3-trifluoromethyl-anilino)-nicotinamide

Conditions
ConditionsYield
With N,N-bis[2-oxo-3-oxazolidinyl]phosphorodiamidic chloride; triethylamine In dichloromethane at 20 - 25℃; for 1h;97%
Niflumic Acid
4394-00-7

Niflumic Acid

2-((4-bromobutanoyl)oxy)propane-1,3-diyl dipalmitate
185672-31-5

2-((4-bromobutanoyl)oxy)propane-1,3-diyl dipalmitate

2-(3-Trifluoromethyl-phenylamino)-nicotinic acid 3-(2-hexadecanoyloxy-1-hexadecanoyloxymethyl-ethoxycarbonyl)-propyl ester

2-(3-Trifluoromethyl-phenylamino)-nicotinic acid 3-(2-hexadecanoyloxy-1-hexadecanoyloxymethyl-ethoxycarbonyl)-propyl ester

Conditions
ConditionsYield
With 1,8-diazabicyclo[5.4.0]undec-7-ene In benzene for 16h; Heating;97%
Niflumic Acid
4394-00-7

Niflumic Acid

o-phthalic dicarboxaldehyde
643-79-8

o-phthalic dicarboxaldehyde

talniflumate

talniflumate

Conditions
ConditionsYield
With 3,5,3',5'-tetra-tert-butyl-4,4'-diphenoquinone; C18H12BrCl3N3O(1+)*BF4(1-); potassium carbonate; lithium chloride In chloroform at 20℃; for 12h; enantioselective reaction;96%
formaldehyd
50-00-0

formaldehyd

Niflumic Acid
4394-00-7

Niflumic Acid

1-(3'-trifluoromethylphenyl)-4H-1,2-dihydro-pyrido-<2,3-d>-<1,3>-oxazin-4-one
137488-34-7

1-(3'-trifluoromethylphenyl)-4H-1,2-dihydro-pyrido-<2,3-d>-<1,3>-oxazin-4-one

Conditions
ConditionsYield
With zinc(II) chloride In chloroform for 24h; Heating;93%
1, 3-dicaprin
17598-93-5

1, 3-dicaprin

Niflumic Acid
4394-00-7

Niflumic Acid

2-(3-Trifluoromethyl-phenylamino)-nicotinic acid 2-decanoyloxy-1-decanoyloxymethyl-ethyl ester

2-(3-Trifluoromethyl-phenylamino)-nicotinic acid 2-decanoyloxy-1-decanoyloxymethyl-ethyl ester

Conditions
ConditionsYield
With allyl bromide; 1,1'-carbonyldiimidazole for 16h; Heating;92%
cholesterol
57-88-5

cholesterol

Niflumic Acid
4394-00-7

Niflumic Acid

2-(3-Trifluoromethyl-phenylamino)-nicotinic acid (3S,8S,9S,10R,13R,14S,17R)-17-((R)-1,5-dimethyl-hexyl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl ester

2-(3-Trifluoromethyl-phenylamino)-nicotinic acid (3S,8S,9S,10R,13R,14S,17R)-17-((R)-1,5-dimethyl-hexyl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl ester

Conditions
ConditionsYield
With allyl bromide; 1,1'-carbonyldiimidazole for 16h; Heating;88%
R,S-5-Brom-2,2-dimethyl-1,3-dioxolan-4-on
134674-19-4

R,S-5-Brom-2,2-dimethyl-1,3-dioxolan-4-on

Niflumic Acid
4394-00-7

Niflumic Acid

2-<3-(Trifluormethyl)phenylamino>-pyridin-3-carbonsaeure-(2,2-dimethyl-1,3-dioxolan-4-on-5-yl)ester
134674-25-2

2-<3-(Trifluormethyl)phenylamino>-pyridin-3-carbonsaeure-(2,2-dimethyl-1,3-dioxolan-4-on-5-yl)ester

Conditions
ConditionsYield
With triethylamine In acetone Ambient temperature;87%
Niflumic Acid
4394-00-7

Niflumic Acid

acetic acid
64-19-7

acetic acid

2-diethylaminoethyl 2-[[3-(trifluoromethyl)phenyl]amino]-3-pyridinecarboxylate acetate

2-diethylaminoethyl 2-[[3-(trifluoromethyl)phenyl]amino]-3-pyridinecarboxylate acetate

Conditions
ConditionsYield
Stage #1: 2-bromo-N,N-diethylethanamine hydrobromide; Niflumic Acid With sodium hydrogencarbonate In water; acetone at 20℃; for 5h;
Stage #2: acetic acid In ethyl acetate; acetone
86.1%
Niflumic Acid
4394-00-7

Niflumic Acid

hexadecanyl bromide
112-82-3

hexadecanyl bromide

2-(3-Trifluoromethyl-phenylamino)-nicotinic acid hexadecyl ester

2-(3-Trifluoromethyl-phenylamino)-nicotinic acid hexadecyl ester

Conditions
ConditionsYield
With 1,8-diazabicyclo[5.4.0]undec-7-ene In benzene for 16h; Heating;85%
1,1-dimethoxyethane
534-15-6

1,1-dimethoxyethane

Niflumic Acid
4394-00-7

Niflumic Acid

1-(3'-trifluoromethylphenyl)-2-methyl-4H-1,2-dihydro-pyrido-<2,3-d>-<1,3>-oxazin-4-one
137488-50-7

1-(3'-trifluoromethylphenyl)-2-methyl-4H-1,2-dihydro-pyrido-<2,3-d>-<1,3>-oxazin-4-one

Conditions
ConditionsYield
With toluene-4-sulfonic acid In toluene for 4h; Heating;83%
hexadecanoic acid, 2-hydroxy-1,3-propanediyl ester
502-52-3

hexadecanoic acid, 2-hydroxy-1,3-propanediyl ester

Niflumic Acid
4394-00-7

Niflumic Acid

2-(3-Trifluoromethyl-phenylamino)-nicotinic acid 2-hexadecanoyloxy-1-hexadecanoyloxymethyl-ethyl ester

2-(3-Trifluoromethyl-phenylamino)-nicotinic acid 2-hexadecanoyloxy-1-hexadecanoyloxymethyl-ethyl ester

Conditions
ConditionsYield
With allyl bromide; 1,1'-carbonyldiimidazole for 16h; Heating;82%
cobalt(II) chloride hexahydrate

cobalt(II) chloride hexahydrate

Bathocuproine
4733-39-5

Bathocuproine

Niflumic Acid
4394-00-7

Niflumic Acid

[Co(bathocuproin)(niflumato)2]

[Co(bathocuproin)(niflumato)2]

Conditions
ConditionsYield
With potassium hydroxide In methanol at 60℃; for 1h;82%
Niflumic Acid
4394-00-7

Niflumic Acid

(E)-3-(4-hydroxy-3-methoxyphenyl)allyl 2-((3-(trifluoromethyl) phenyl)amino)nicotinate

(E)-3-(4-hydroxy-3-methoxyphenyl)allyl 2-((3-(trifluoromethyl) phenyl)amino)nicotinate

Conditions
ConditionsYield
Stage #1: coniferal alcohol With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; for 0.5h; Steglich Esterification; Inert atmosphere;
Stage #2: Niflumic Acid In dichloromethane at 20℃; for 24.5h; Steglich Esterification; Inert atmosphere;
81%
3-Bromophthalide
6940-49-4

3-Bromophthalide

Niflumic Acid
4394-00-7

Niflumic Acid

talniflumate
66898-62-2

talniflumate

Conditions
ConditionsYield
With triethylamine; sodium iodide In acetone for 2h; Heating;80%
With triethylamine In water; acetone52% (20.5 g)
Niflumic Acid
4394-00-7

Niflumic Acid

Hexadecanoic acid 3-hexadecanoyloxy-2-(4-hydroxy-butyryloxy)-propyl ester
185672-32-6

Hexadecanoic acid 3-hexadecanoyloxy-2-(4-hydroxy-butyryloxy)-propyl ester

2-(3-Trifluoromethyl-phenylamino)-nicotinic acid 3-(2-hexadecanoyloxy-1-hexadecanoyloxymethyl-ethoxycarbonyl)-propyl ester

2-(3-Trifluoromethyl-phenylamino)-nicotinic acid 3-(2-hexadecanoyloxy-1-hexadecanoyloxymethyl-ethoxycarbonyl)-propyl ester

Conditions
ConditionsYield
With allyl bromide; 1,1'-carbonyldiimidazole In chloroform for 16h; Heating;80%
3-Methylpyridine
108-99-6

3-Methylpyridine

copper(II) choride dihydrate

copper(II) choride dihydrate

Niflumic Acid
4394-00-7

Niflumic Acid

[Cu2Cl2(niflumic acid(-H))2(3‐picoline)4]

[Cu2Cl2(niflumic acid(-H))2(3‐picoline)4]

Conditions
ConditionsYield
Stage #1: 3-Methylpyridine; copper(II) choride dihydrate In methanol at 50℃;
Stage #2: Niflumic Acid With potassium hydroxide In methanol for 0.5h;
80%
Chloromethyl pivalate
18997-19-8

Chloromethyl pivalate

Niflumic Acid
4394-00-7

Niflumic Acid

2-<<3-(trifluormetil)fenil>amino>-3-piridincarboxilato de pivaloiloximetilo
66898-68-8

2-<<3-(trifluormetil)fenil>amino>-3-piridincarboxilato de pivaloiloximetilo

Conditions
ConditionsYield
With triethylamine; sodium iodide In acetone for 4h; Heating;79.5%

Niflumic acid Specification

The Niflumic acid, with the CAS registry number 4394-00-7, is also known as 7-Oxabicyclo[2.2.1]heptane-2,3-dicarboxylic anhydride. It belongs to the product categories of Acids and Derivatives; Heterocycles; Active Pharmaceutical Ingredients; API intermediates; Aromatics; Inhibitors; Intermediates & Fine Chemicals; Pharmaceuticals. Its EINECS number is 224-516-2. This chemical's molecular formula is C13H9F3N2O2 and molecular weight is 282.22. What's more, its systematic name is 2-{[3-(Trifluoromethyl)phenyl]amino}nicotinic acid. Its classification codes are: (1)Analgesics; (2)Analgesics, Non-Narcotic; (3)Anti-Inflammatory Agents; (4)Anti-inflammatory agents, non-steroidal; (5)Antirheumatic Agents; (6)Cyclooxygenase inhibitors; (7)Drug / Therapeutic Agent; (8)Enzyme Inhibitors; (9)Peripheral Nervous System Agents; (10)Reproductive Effect; (11)Sensory System Agents. Niflumic acid is a drug used for joint and muscular pain. It is categorized as an inhibitor of cyclooxygenase-2. In experimental biology, it has been employed to inhibit chloride channels. It is an analgesic and anti-inflammatory agent used in the treatment of rheumatoid arthritis. It is stable at common pressure and temperature, and it should be sealed and stored in a ventilated and dry place. Moreover, it should be protected from light. This chemical can be prepared by 2-chloro pyridine-3-carboxylic acid and m-trifluoromethyl aniline.

Physical properties of Niflumic acid are: (1)ACD/LogP: 4.46; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): 2.14; (4)ACD/LogD (pH 7.4): 1.35; (5)ACD/BCF (pH 5.5): 6.94; (6)ACD/BCF (pH 7.4): 1.11; (7)ACD/KOC (pH 5.5): 30.54; (8)ACD/KOC (pH 7.4): 4.88; (9)#H bond acceptors: 4; (10)#H bond donors: 2; (11)#Freely Rotating Bonds: 2; (12)Polar Surface Area: 62.22 Å2; (13)Index of Refraction: 1.589; (14)Molar Refractivity: 65.629 cm3; (15)Molar Volume: 194.738 cm3; (16)Polarizability: 26.017×10-24cm3; (17)Surface Tension: 48.57 dyne/cm; (18)Density: 1.449 g/cm3; (19)Flash Point: 182.436 °C; (20)Enthalpy of Vaporization: 66.024 kJ/mol; (21)Boiling Point: 378.046 °C at 760 mmHg; (22)Vapour Pressure: 0 mmHg at 25°C.

Uses of Niflumic acid: it can be used to produce 2-{[3-(trifluormetil)fenil]amino}-3-piridincarboxilato de ftalidilo by heating. It will need reagents triethylamine, sodium iodide and solvent acetone with the reaction time of 2 hours. The yield is about 80%.

Niflumic acid can be used to produce 2-{[3-(trifluormetil)fenil]amino}-3-piridincarboxilato de ftalidilo by heating

When you are using this chemical, please be cautious about it as the following:
This chemical is harmful by inhalation, in contact with skin and if swallowed. It is irritating to eyes, respiratory system and skin. In case of contact with eyes, you should rinse immediately with plenty of water and seek medical advice. When using it, you need to wear suitable protective clothing, gloves and eye/face protection.

You can still convert the following datas into molecular structure:
(1)SMILES: FC(F)(F)c1cc(ccc1)Nc2ncccc2C(=O)O
(2)Std. InChI: InChI=1S/C13H9F3N2O2/c14-13(15,16)8-3-1-4-9(7-8)18-11-10(12(19)20)5-2-6-17-11/h1-7H,(H,17,18)(H,19,20)
(3)Std. InChIKey: JZFPYUNJRRFVQU-UHFFFAOYSA-N

The toxicity data is as follows:

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
guinea pig LD50 intravenous 174mg/kg (174mg/kg)   United States Patent Document. Vol. #3466373,
mouse LD50 intraperitoneal 196mg/kg (196mg/kg)   Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 68, Pg. 683, 1972.
mouse LD50 intravenous 152mg/kg (152mg/kg)   Therapie. Vol. 22, Pg. 157, 1967.
mouse LD50 oral 350mg/kg (350mg/kg)   United States Patent Document. Vol. #4122202,
rat LD50 intraperitoneal 100mg/kg (100mg/kg)   United States Patent Document. Vol. #3466373,
rat LD50 oral 250mg/kg (250mg/kg) BEHAVIORAL: ANALGESIA Journal of Medicinal Chemistry. Vol. 16, Pg. 780, 1973.

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View